Global Differences On Patents Lead WIPO Patent Law Committee To Stumble On Future Work

WIPO Standing Committee on the Law of Patents

Once again, differences over the role of a World Intellectual Property Organization committee last week came in the way of consensus and prevented delegates from agreeing on future work. At the heart of the discontent was the perceived imbalance of the proposed programme of work, which some said disregarded the interests of developing countries. A speaker for the African region gave a striking speech on the Ebola crisis as an example of the failure of the patent system.

Expect Strong IP Push From Global Pharma Industry Next Year; WHO Prescribes Dose Of Reality

Medicines - FLickr - Nina Matthews

NEW YORK – Strong intellectual property rights will be a top priority for the pharmaceutical industry internationally in the coming year and arguments over IPRs versus medicines access are false, a top representative said at a high-level industry event this week. But views at the event differed on expectations of industry in light of the Ebola crisis, hepatitis C drug costs or other medicines access questions.

WTO, WHO, WIPO Examine IPRs And Middle-Income Countries

Health - Flickr - 401KCalculator.org

The current income-based grouping of countries needs to be changed or access to medicines in middle-income countries will worsen, several speakers said yesterday at a joint meeting between three international organisations on health, trade, and intellectual property. But middle-income countries should step up their engagement in organisations such as the World Health Organization, according to WHO and civil society.

Limitations And Exceptions To Patent Rights Discussed In WIPO Committee

invention equation on whiteboard

The World Intellectual Property Organization patent law committee this week is addressing a range of issues including patent quality, technology transfer for medicine production, limitations and exceptions to patents, and the confidentiality of communications between clients and their patent advisors.

TRIPS Council Debates: Tobacco Packaging, Non-Violation Disputes, Innovation, Health Waiver, UNCTAD

Enough of a deterrent?

This week’s meeting of the World Trade Organization body governing intellectual property issues addressed a long agenda, reflecting continued divergence on regular items, such as complaints that do not involve breach of a WTO agreement, a health waiver, and sustained discussions on plain packaging for tobacco products.

WHO Ebola Vaccine Meeting Draws Commitment From Pharma, Donors; MSF Sees Need For Concrete Actions

Ebola Vaccine - Flickr - NIAID

A high-level meeting convened by the World Health Organization yesterday on the issue of access to and financing of Ebola vaccines resulted in a set of commitments, though not with sufficient urgency for those working on the ground. The pharmaceutical industry committed to scale up production, while donors pledged funds without disclosing how deep their pockets might be.

Life Sciences Stakeholders Assess Accessing Emerging Markets

Conference emerging-market-access Oct 2014

PARIS –Life sciences stakeholders at a recent conference explored matters associated with market access in the BRICS (Brazil, Russia, India, China, South Africa) and in the Middle East and North Africa regions.

TRIPS Council Next Week: Tobacco, Innovation, Non-Violations, Public Health Review

WTO   - Catherine Saez

The next meeting of the World Trade Organization Council on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is scheduled to take place on 28-29 October. In addition to the regular agenda items of the Council, two additional agenda items have been submitted by members, relating to tobacco plain packaging and innovation. Image Credits: Catherine Saez

WTO Director General Presents TRIPS As Major Tool For Trade Growth

Azevedo Federal Bar Asso - Oct 2014 - WTO

World Trade Organization Director General Roberto Azevêdo this week hailed WTO’s intellectual property agreement, saying the past two decades show it provides a balanced multilateral foundation for the growth of trade in knowledge-rich products and services.

Ebola Vaccine Candidates Centre Of Attention; Clinical Trials, IP Negotiations Start

vaccines

Today, the World Health Organization gave a press briefing to update journalists on what to expect in the near future on Ebola treatments and vaccines.